Shenmayizhi Formula Combined with Ginkgo Extract Tablets for the Treatment of Vascular Dementia: A Randomized, Double-Blind, Controlled Trial

Table 6

Comparison of CM-SS scores in the 2 groups before and after treatment.

Symptom	SMYZF group (n = 85), median (IQR)	Ginkgo group (n = 87), median (IQR)	value
Intelligence decline
Before treatment	3 (3–6)	3 (3–6)	0.419
After treatment	0 (0–3)	3 (0–6)	0.006
Soreness and weakness of the waist and knees
Before treatment	4 (2–4)	4 (2–4)	0.970
After treatment	2 (0–4)	2 (0–4)	0.570
Restlessness
Before treatment	1 (0–2)	1 (0–2)	0.509
After treatment	0 (0–1)	1 (1–2)	<0.001
Rigid and silent
Before treatment	0 (0–2)	0 (0–2)	0.792
After treatment	0 (0–2)	0 (0–0)	0.088
Spasm and numb of limbs
Before treatment	1 (1–1)	1 (0–1)	0.531
After treatment	1 (0–1)	1 (0–1)	0.077
Cardiopalmus
Before treatment	1 (0–2)	1 (0–1)	0.890
After treatment	0 (0–1)	0 (0–1)	0.909
Irritability
Before treatment	1 (0–1)	1 (0–1)	0.380
After treatment	0 (0–1)	0 (0–2)	0.001
Dry skin
Before treatment	0 (0–1)	0 (0–1)	0.615
After treatment	0 (0–1)	0 (0–1)	0.927
Cyanosis of the lips
Before treatment	1 (1–2)	1 (1–2)	0.948
After treatment	1 (0–1)	1 (0–2)	0.013
Enuresis nocturna
Before treatment	2 (1–2)	2 (1–2)	0.071
After treatment	2 (0.5–2)	2 (1–2)	0.713
Tinnitus
Before treatment	1 (0–2)	1 (0–3)	0.166
After treatment	1 (0–1)	1 (0–2)	0.735
Total scores
Before treatment	17 (11–20)	16 (11–21)	0.844
After treatment	10 (6–13)	11 (7–18)	0.033

Significant effect ( < 0.05).